A decision support tool designed specifically for oncologists.
In an era where the complexity of cancer care is growing exponentially, oncologists need clear, actionable insights to make the best decisions for their patients. The Perthera Report® simplifies vast amounts of data into precise ranked treatment recommendations, empowering oncologists to choose the most effective personalized therapies.
The Perthera Report delivers ranked, detailed personalized therapy options based on your patient’s unique tumor profile, multi-omics, and medical history. This helps oncologists match patients to the cancer therapy that will deliver the best outcome.
Let us show you how
Contact Us Download a report2.4X
Improvement with Progression Free Survival with Perthera
A published peer-reviewed study showed that patients experienced 2.4X longer progression-free survival (PFS) when oncologists followed the Perthera Report recommendations
ONCOLOGISTS FROM RURAL HOSPITALS TO NCI-DESIGNATED CANCER CENTERS INTEGRATE THE PERTHERA REPORT INTO TREATMENT PLANS
Johns Hopkins
New York Presbyterian Hospital
Sharp Memorial Hospital
Baylor Scott & White
City of Hope
Jefferson
Mayo Clinic
MD Anderson Cancer Center
Seattle Cancer Care Alliance
University of Vermont Health Network
UVA Health
Virginia Mason Franciscan Health Logo
STAY AHEAD OF THE CURVE AND PROVIDE LEADING CARE
The Perthera Report features:
1. Tailored therapy options
The report provides personalized therapy recommendations based on your patient’s unique tumor profile, multi-omics, and medical history. Each report ranks treatment options for your patient, including on-label, off-label, and clinical trials, by integrating molecular profiling,clinical history and Perthera’s Real-World-Evidence (RWE) data.
2. Expert guidance tailored to each cancer specialty
Perthera has a “human in the loop” with a Virtual Molecular Tumor Board (MTB) that ensures precision through multi-disciplinary expertise. Specialists tailor recommendations to the specific cancer , reflecting the latest advancements in oncology.
3. Actionable AI and expert backed insights you can trust
Our AI-powered algorithms rank therapy options based on the latest published research and clinical guidelines, patient-specific molecular data and individual medical history, and expert input from our virtual MTB, composed of medical and multi-omic specialists and from the body of Perthera’s real-world-evidence collected from over a decade of previous patients.
Each report provides clear, evidence-based rationale. Recommendations are supported by evidence, detailed ratoinale, and references to empowe confident decision making.
4. We give you more time to care for your patient
The Perthera Report streamlines care planning by providing ranked treatment options supported by the latest research, guidelines, and actionable NGS insights. This saves you time otherwise spent on extensive research, allowing you to focus more on your patients.
ONCOLOGISTS CHOOSE THE PERTHERA REPORT TO CREATE BETTER TREATMENT PLANS
01
Deliver Improved patient outcomes – 2.4 x in a recent peer reviewed study
Your patients rely on you for life-changing care. The Perthera Report provides the tools, insights, and expert support you need to deliver precision treatments that improve outcomes and quality of life. Peer-reviewed studies show the Perthera Report improves outcomes by 2.4 times. Precision insights and expert guidance lead to life-changing care and improved quality of life.
02
Collaborate with leading experts to get their treatment recommendations
Gain treatment recommendations from top oncology specialists through the Virtual Molecular Tumor Board, ensuring decisions are informed by cutting-edge expertise.
03
Simplify complex NGS testing data
The Perthera Report transforms overwhelming NGS testing data into concise, actionable insights, helping you focus on what matters most—patient care.
04
Stay ahead in a rapidly evolving field
With new therapies, research, and guidelines emerging daily, staying current is challenging. The Perthera Report keeps you informed with recommendations grounded on the latest evidence, guidelines, and expert opinions.
05
Make confident, personalized decisions
Receive ranked, evidence-based therapy options tailored to your patient’s unique tumor profile and medical history. With clear rationales and references to support , confident decision making.
The Perthera Report delivers ranked, detailed personalized therapy options based on your patient’s unique tumor profile, multi-omics, and medical history. This helps oncologists match patients to the cancer therapy that will deliver the best outcome.